Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy

NCT01248117 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Retina Consultants of Hawaii

Collaborators